Ardelyx reported $-29.77M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Amgen USD 3.86B 1.28B Mar/2026
Ardelyx USD -29.77M 35.79M Mar/2026
aTyr Pharma USD -54K 25.9M Mar/2026
Corcept Therapeutics USD -49M 53.2M Mar/2026
Curis USD -12.3M 231K Sep/2023
Sanofi EUR 2.72B 2.94B Mar/2026
TG Therapeutics USD 26.9M 1.21M Jun/2026
United Therapeutics USD 355M 11.1M Jun/2026